We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
CIRS

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid an... read more Featured Products: More products

Download Mobile App





iCAD Presents Latest AI Solution for Digital Breast Tomosynthesis

By MedImaging International staff writers
Posted on 28 Feb 2019
Print article
Image: ProFound AI offers an average of 8% in cancer detection rates, and a reduction by an average of 7% in the rate of unnecessary patient recalls (Photo courtesy of iCAD).
Image: ProFound AI offers an average of 8% in cancer detection rates, and a reduction by an average of 7% in the rate of unnecessary patient recalls (Photo courtesy of iCAD).
iCAD Inc. (Nashua, NH, USA), a provider of cancer detection and therapy solutions, presented its latest artificial intelligence (AI) software solution for digital breast tomosynthesis (DBT), ProFound AI, during the European Congress of Radiology (ECR) 2019, the second-largest radiological meeting in the world. Held by the European Society of Radiology, the conference took place February 27 through March 3, 2019, in Vienna, Austria.

ProFound AI is a deep-learning, cancer detection and workflow solution for DBT that delivers critical benefits to radiologists, their facilities and patients through an improvement by an average of 8% in cancer detection rates and a reduction by an average of 7% in the rate of unnecessary patient recalls. The technology is designed to detect malignant soft-tissue densities and calcifications and provides radiologists with the certainty of finding lesion and case scores.

At ECR 2019, iCAD previewed ProFound AI for 2D mammography, which is built on deep learning technology and is currently pending CE mark. iCAD also led two clinical presentations during the conference and hosted an event entitled, “AI After Dark.”

“With growing global demand for cancer detection and workflow solutions built on the latest advances in deep-learning, we are thrilled to demonstrate the unrivaled capabilities of our ProFound AI solution, which is clinically proven to help clinicians detect more cancers, decrease false positives and reduce recalls and reading time,” said Stacey Stevens, Executive Vice President and Chief Strategy and Commercial Officer at iCAD. “ProFound AI offers tremendous benefits to radiologists and their patients in identifying cancer earlier. We look forward to expanding the unique capabilities of our algorithm through new application areas, including breast cancer risk prediction, in the future.”


Print article
Sun Nuclear
Radcal

Channels

Radiography

view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more

MRI

view channel
Image: fMRI can be used as non-invasive method for predicting complications in chronic liver disease (Photo courtesy of Pexels)

Functional MRI (fMRI) Offers Non-Invasive Method for Risk Assessment in Liver Disease

In a recent study, a team of scientists has shown that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease.... Read more

Ultrasound

view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.